CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 67 enrolled
Drug / intervention
3D TEE RVEFother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05804240
NCT05804240N/ACompleted
CompareCT.gov

Utility of Three-dimensional Transesophageal Echocardiography in Right Ventricular Function Assessment in Surgical Aortic Valve Replacement, Mini-sternotomy Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement

Thomas Jefferson University·observational·Posted Apr 7, 2023·Updated May 13, 2026

In Brief

An observational study evaluating 3D TEE RVEF for Right Ventricular Dysfunction. Completed, enrolled 67 participants across 1 site.

Detailed Summary

Three-dimensional echocardiography has become a gold standard to assess right ventricular (RV) function, and investigators plan to use 3D transesophageal echocardiography to assess RV function in 3 types of aortic valve replacement (AVR): full sternotomy surgical AVR (full-SAVR), mini-sternotomy surgical AVR (mini-SAVR), and transcatheter AVR (TAVR).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRight Ventricular Dysfunction
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedApr 7, 2023
Enrollment StartApr 1, 2023
Primary CompletionJun 30, 2025
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 3.2 years ago

Interventions

3D TEE RVEFother

With TEE package software, the investigators measure and calculate 3D TEE RVEF using mid esophageal 4 chamber view